Skip to content

Reported October 29, 2025 · After market close

Revenue$143.8MMiss by $11.6M
EPS$0.66Beat by $0.29
Revenue estimate$155.4M
EPS estimate$0.37

Next report

Aug 4, 2026 (In 5 days)
Revenue estimate$183.8M
EPS estimate$0.50

Financials

Q3 2025

Income statement

See full
Revenue$143.8M+32.2%
Gross profit$84.6M+39.0%
Operating income$23.3M+494%
Net income$24.3M+477%
EPS (diluted)$0.66+450%

Balance sheet

See full
Cash & equivalents$466.2M+41.2%
Total debt$67.3M-2.4%
Total equity$355.2M+69.2%
Total assets$946.0M+20.4%

Cash flow

See full
Operating cash flow$69.6M+915%
CapEx$7.6M-84.2%
Free cash flow$61.9M+250%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$3.82B-27.1%
Enterprise value$3.43B-31.3%
P/E41.7×
P/S6.8×-6.3×

Profitability

See full
Gross margin60.3%+0.9pp
Operating margin16.9%+9.7pp
Net margin16.2%

Returns & leverage

See full
Return on equity32.5%
Debt / equity0.2×-0.1×
Current ratio7.7×-0.5×

Segments

By product

See full
Liver Product$107.9M+40.8%
Heart Product$30.6M+13.6%
Lung Product$4.1M+5.2%

By segment

See full
Ocs Transplant Revenue$142.6M+32.7%

Versus estimates

Ask the moment TransMedics Group, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did TransMedics Group, Inc. report Q3 2025 earnings?
TransMedics Group, Inc. (TMDX) reported Q3 2025 earnings on October 29, 2025 after market close.
What were TransMedics Group, Inc.'s Q3 2025 revenue and EPS?
TransMedics Group, Inc. reported revenue of $143.8M and eps of $0.66 for Q3 2025.
Did TransMedics Group, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $155.4M by $11.6M. EPS beat the consensus estimate of $0.37 by $0.29.
How did TransMedics Group, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 32.2% from $108.8M a year earlier and eps grew 450.0% from $0.12.
Where can I find TransMedics Group, Inc.'s Q3 2025 SEC filings?
You can read the 10-Q periodic report (0001193125-25-256377) directly on SEC EDGAR. The filing index links above go to sec.gov.